Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (9076)	3/10/1999 2:34:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Just to complete a thought: <"Finally, if mortality is 10% in the placebo group we should expect the study to continue for the next 1 or 2 years if they could recruit some 800 to 1000 patients during that time."> Since Jack Castello said they are close to the number required I agree with Gonzalez that they mean this and are not in anyway playing any game and that they know it will not take more than a few weeks and in no way end up being years. Meaning of course that the mortality is higher for placebo cases, IMO, than some are now thinking. Perhaps more importantly is the fact that the market apparently understands that what is happening is bullish. Many of us regular posters are tired out and discouraged. Some of this comes from feeling XOMA could have and should have said more. The "market" does not care about any of this and I think I will just sit back and see what happens next.